Other · developed by Bausch Health Americas
IDP-120 is a topical gel applied once daily.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT03664752 | Phase 3 | Acne Vulgaris | Completed | BHC |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Acne Vulgaris
Updated Oct 25, 2026. Something wrong or missing? Report it on the BHC page.
See BHC's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
BHC catalysts and pipeline →